Condition
Cerebral Amyloid Angiopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Cerebral Amyloid Angiopathy clinical trials that are recruiting, at sites in 4 countries (most in Italy (3), China (2), United States (1)). By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 4Countries
Newest Cerebral Amyloid Angiopathy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Jiedu Huayu oral medicine for brain hemorrhage due to cerebral amyloid angiopathy | Phase 3 | Beijing | Recruiting | Nov 25, 2025 |
| Colchicine to prevent repeat lobar brain bleeds from cerebral amyloid angiopathy | Phase 2 | Beijing and 2 other locations | Recruiting | Jun 18, 2025 |
| Impact of the Mediterranean Diet on patients with CADASIL and Cerebral Amyloid Angiopathy | — | Milan | Recruiting | Apr 18, 2025 |
| Using a digital twin app to support people in secondary prevention after stroke, Moyamoya disease, or cerebral amyloid angiopathy | — | Milan, Michigan | Recruiting | Dec 3, 2024 |
| Understanding the prognosis of cerebral small vessel disease | — | Bern | Recruiting | Feb 17, 2023 |
| Evaluating AMDX-2011P for treating cerebral amyloid angiopathy | Phase 2 | Phoenix, Arizona | Recruiting | Feb 2, 2023 |
| Identifying biomarkers for cerebral amyloid angiopathy | — | Milan, Milano | Recruiting | Dec 19, 2019 |
All recruiting trials (7)
-
Jiedu Huayu oral medicine for brain hemorrhage due to cerebral amyloid angiopathy
This trial tests a traditional Chinese medicine oral prescription against placebo to see if it can reduce recurrent vascular events in patients with cerebral amyloid angiopathy-related intracerebral hemorrhage.
-
Colchicine to prevent repeat lobar brain bleeds from cerebral amyloid angiopathy
This trial will test whether taking a daily low-dose colchicine pill for a year is safe and helps prevent repeat lobar intracerebral hemorrhage in people with cerebral amyloid angiopathy who are at high risk of another bleed.
-
Impact of the Mediterranean Diet on patients with CADASIL and Cerebral Amyloid Angiopathy
This study is testing whether following the Mediterranean Diet can help people with CADASIL and Cerebral Amyloid Angiopathy feel better and reduce their risk of strokes and cognitive decline.
-
Using a digital twin app to support people in secondary prevention after stroke, Moyamoya disease, or cerebral amyloid angiopathy
This trial will try the STRATIF-AI app plus usual secondary prevention care to see if it improves daily self-care and the patient experience for adults after stroke, Moyamoya disease, or CAA.
-
Understanding the prognosis of cerebral small vessel disease
This study looks at how different types of cerebral small vessel disease affect the health and future outcomes of patients, including issues like bleeding in the brain and memory problems.
-
Evaluating AMDX-2011P for treating cerebral amyloid angiopathy
This study is testing a new drug called AMDX-2011P to see if it is safe and effective for people with cerebral amyloid angiopathy.
-
Identifying biomarkers for cerebral amyloid angiopathy
This study is trying to find signs that show how cerebral amyloid angiopathy affects older people, to help doctors better understand and treat the condition.
Related topics
Quick answers
How many Cerebral Amyloid Angiopathy clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Italy (3 trials), China (2 trials), United States (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.